Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kevin Pethe

Showing results (111-120 of 115) with videos related to

Pageof 12
Sort By:
You have reached the last page of results.This site can display upto 115 results.
ACS Medicinal Chemistry Letters|June 6, 2014
Discovery of tetrahydropyrazolopyrimidine carboxamide derivatives as potent and orally active antitubercular agentsFumiaki Yokokawa, Gang Wang, Wai Ling Chan, et al.
Nature Communications|July 12, 2025
Carbene formation as a mechanism for efficient intracellular uptake of cationic antimicrobial carbon acid polymersChong Hui Koh, Mallikharjuna Rao Lambu, Chongyun Tan, et al.
Science Translational Medicine|December 6, 2013
Indolcarboxamide is a preclinical candidate for treating multidrug-resistant tuberculosisSrinivasa P S Rao, Suresh B Lakshminarayana, Ravinder R Kondreddi, et al.
Nature Communications|October 27, 2010
A chemical genetic screen in Mycobacterium tuberculosis identifies carbon-source-dependent growth inhibitors devoid of in vivo efficacyKevin Pethe, Patricia C Sequeira, Sanjay Agarwalla, et al.
Nature Medicine|August 6, 2013
Discovery of Q203, a potent clinical candidate for the treatment of tuberculosisKevin Pethe, Pablo Bifani, Jichan Jang, et al.
Pageof 12

Showing results (111-120 of 115) with videos related to

Sort By:
Pageof 12
You have reached the last page of results.This site can display upto 115 results.
ACS Medicinal Chemistry Letters|June 6, 2014
Discovery of tetrahydropyrazolopyrimidine carboxamide derivatives as potent and orally active antitubercular agentsFumiaki Yokokawa, Gang Wang, Wai Ling Chan, et al.
Nature Communications|July 12, 2025
Carbene formation as a mechanism for efficient intracellular uptake of cationic antimicrobial carbon acid polymersChong Hui Koh, Mallikharjuna Rao Lambu, Chongyun Tan, et al.
Science Translational Medicine|December 6, 2013
Indolcarboxamide is a preclinical candidate for treating multidrug-resistant tuberculosisSrinivasa P S Rao, Suresh B Lakshminarayana, Ravinder R Kondreddi, et al.
Nature Communications|October 27, 2010
A chemical genetic screen in Mycobacterium tuberculosis identifies carbon-source-dependent growth inhibitors devoid of in vivo efficacyKevin Pethe, Patricia C Sequeira, Sanjay Agarwalla, et al.
Nature Medicine|August 6, 2013
Discovery of Q203, a potent clinical candidate for the treatment of tuberculosisKevin Pethe, Pablo Bifani, Jichan Jang, et al.
Pageof 12